Skip Header

1 - 25 of 110 results for author:"Koike K." in Literature citations

Page of 5 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (197)

Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.

Kumar V., Yi Lo P.H., Sawai H., Kato N., Takahashi A., Deng Z., Urabe Y., Mbarek H., Tokunaga K., Tanaka Y. et al.

PLoS ONE 7:e44743-e44743(2012) · Mapped (46)

Silencing of microRNA-122 enhances interferon-alpha signaling in the liver through regulating SOCS3 promoter methylation.

Yoshikawa T., Takata A., Otsuka M., Kishikawa T., Kojima K., Yoshida H., Koike K.

Sci Rep 2:637-637(2012) · Mapped (3)

Modulation of lipid metabolism with the overexpression of NPC1L1 in mouse liver.

Kurano M., Hara M., Tsuneyama K., Okamoto K., Iso-O N., Matsushima T., Koike K., Tsukamoto K.

J. Lipid Res. 53:2275-2285(2012) · Mapped (13)

Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemia.

Doisaki S., Muramatsu H., Shimada A., Takahashi Y., Mori-Ezaki M., Sato M., Kawaguchi H., Kinoshita A., Sotomatsu M., Hayashi Y. et al.

Blood 120:1485-1488(2012) · Mapped (4)

Periostin promotes chronic allergic inflammation in response to Th2 cytokines.

Masuoka M., Shiraishi H., Ohta S., Suzuki S., Arima K., Aoki S., Toda S., Inagaki N., Kurihara Y., Hayashida S. et al.

J. Clin. Invest. 122:2590-2600(2012) · Mapped (8)

Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents.

Kageyama Y., Ikeda H., Watanabe N., Nagamine M., Kusumoto Y., Yashiro M., Satoh Y., Shimosawa T., Shinozaki K., Tomiya T. et al.

Hepatology 56:1427-1438(2012) · Mapped (2)

A miRNA machinery component DDX20 controls NF-kappaB via microRNA-140 function.

Takata A., Otsuka M., Yoshikawa T., Kishikawa T., Kudo Y., Goto T., Yoshida H., Koike K.

Biochem. Biophys. Res. Commun. 420:564-569(2012) · Mapped (6)

Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation.

Kudo Y., Tateishi K., Yamamoto K., Yamamoto S., Asaoka Y., Ijichi H., Nagae G., Yoshida H., Aburatani H., Koike K.

Cancer Sci. 103:670-676(2012) · Mapped (1)

Receptor for activated protein kinase C: requirement for efficient microRNA function and reduced expression in hepatocellular carcinoma.

Otsuka M., Takata A., Yoshikawa T., Kojima K., Kishikawa T., Shibata C., Takekawa M., Yoshida H., Omata M., Koike K.

PLoS ONE 6:e24359-e24359(2011) · Mapped (10)

Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.

Ijichi H., Chytil A., Gorska A.E., Aakre M.E., Bierie B., Tada M., Mohri D., Miyabayashi K., Asaoka Y., Maeda S. et al.

J. Clin. Invest. 121:4106-4117(2011) · Mapped (15)

Factor H gene variants in Japanese: its relation to atypical hemolytic uremic syndrome.

Mukai S., Hidaka Y., Hirota-Kawadobora M., Matsuda K., Fujihara N., Takezawa Y., Kubota S., Koike K., Honda T., Yamauchi K.

Mol. Immunol. 49:48-55(2011) · Mapped (5)

Genetic analysis of TP53 in childhood myelodysplastic syndrome and juvenile myelomonocytic leukemia.

Saito S., Matsuda K., Taira C., Sano K., Tanaka-Yanagisawa M., Yanagisawa R., Nakazawa Y., Sakashita K., Shiohara M., Koike K.

Leuk. Res. 35:1578-1584(2011) · Mapped (32)

Altered composition of fatty acids exacerbates hepatotumorigenesis during activation of the phosphatidylinositol 3-kinase pathway.

Kudo Y., Tanaka Y., Tateishi K., Yamamoto K., Yamamoto S., Mohri D., Isomura Y., Seto M., Nakagawa H., Asaoka Y. et al.

J. Hepatol. 55:1400-1408(2011) · Mapped (2)

Isolation and characterization of a single-stranded DNA virus infecting Chaetoceros lorenzianus Grunow.

Tomaru Y., Takao Y., Suzuki H., Nagumo T., Koike K., Nagasaki K.

Appl. Environ. Microbiol. 77:5285-5293(2011) · UniProtKB (3)

MicroRNA122 is a key regulator of alpha-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma.

Kojima K., Takata A., Vadnais C., Otsuka M., Yoshikawa T., Akanuma M., Kondo Y., Kang Y.J., Kishikawa T., Kato N. et al.

Nat Commun 2:338-338(2011) · Mapped (11)

Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population.

Tanabe T., Yamaguchi N., Matsuda K., Yamazaki K., Takahashi S., Tojo A., Onizuka M., Eishi Y., Akiyama H., Ishikawa J. et al.

Int. J. Hematol. 93:771-778(2011) · Mapped (8)

Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.

Kumar V., Kato N., Urabe Y., Takahashi A., Muroyama R., Hosono N., Otsuka M., Tateishi R., Omata M., Nakagawa H. et al.

Nat. Genet. 43:455-458(2011) · Mapped (46)

Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase.

Nakagawa H., Hirata Y., Takeda K., Hayakawa Y., Sato T., Kinoshita H., Sakamoto K., Nakata W., Hikiba Y., Omata M. et al.

Hepatology 54:185-195(2011) · Mapped (3)

Specific increase in serum autotaxin activity in patients with pancreatic cancer.

Nakai Y., Ikeda H., Nakamura K., Kume Y., Fujishiro M., Sasahira N., Hirano K., Isayama H., Tada M., Kawabe T. et al.

Clin. Biochem. 44:576-581(2011) · Mapped (3)

Autotaxin as a novel serum marker of liver fibrosis.

Nakagawa H., Ikeda H., Nakamura K., Ohkawa R., Masuzaki R., Tateishi R., Yoshida H., Watanabe N., Tejima K., Kume Y. et al.

Clin. Chim. Acta 412:1201-1206(2011) · Mapped (3)

Effect of a fermented nutraceutical on thioredoxin level and TNF-alpha signalling in cirrhotic patients.

Marotta F., Chui D.H., Jain S., Polimeni A., Koike K., Zhou L., Lorenzetti A., Shimizu H., Yang H.

J. Biol. Regul. Homeost. Agents 25:37-45(2011) · Mapped (6)

Expression of junB is markedly stimulated by glycyrrhizin in a human hepatoma cell line.

Koike K.

Oncol. Rep. 25:609-617(2011) · Mapped (3)

Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer.

Hayakawa Y., Hirata Y., Nakagawa H., Sakamoto K., Hikiba Y., Kinoshita H., Nakata W., Takahashi R., Tateishi K., Tada M. et al.

Proc. Natl. Acad. Sci. U.S.A. 108:780-785(2011) · Mapped (20)

Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients.

Arano T., Nakagawa H., Tateishi R., Ikeda H., Uchino K., Enooku K., Goto E., Masuzaki R., Asaoka Y., Kondo Y. et al.

Int. J. Cancer 129:2226-2235(2011) · Mapped (3)

Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.

Takagi M., Shinoda K., Piao J., Mitsuiki N., Takagi M., Matsuda K., Muramatsu H., Doisaki S., Nagasawa M., Morio T. et al.

Blood 117:2887-2890(2011) · Mapped (7)

to top of page·

Page of 5 | Next »